Genetically Engineered Animals, Drugs, and Neoliberalism: The Need for a New Biotechnology Regulatory Policy Framework
Author:
- 21 November 2017
- journal article
- research article
- Published by Springer Nature in Journal of Agricultural and Environmental Ethics
- Vol. 30 (6) , 715-743
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Risk Assessment of Genetically Modified Food and Neoliberalism: An Argument for Democratizing the Regulatory Review Protocol of the Food and Drug AdministrationJournal of Agricultural and Environmental Ethics, 2014
- The “Revolving Door” between Regulatory Agencies and Industry: A Problem That Requires Reconceptualizing ObjectivityJournal of Agricultural and Environmental Ethics, 2010
- Containing the Atom: Sociotechnical Imaginaries and Nuclear Power in the United States and South KoreaMinerva, 2009
- The U.S. Food and Drug Administration's Evaluation of the Safety of Animal ClonesBulletin of Science, Technology & Society, 2009
- Recasting “Substantial Equivalence”:Transatlantic Governance of GM FoodScience, Technology, & Human Values, 2007
- Nanotechnology, Governance, and Public Deliberation: What Role for the Social Sciences?Science Communication, 2005
- Why America Needs a Strong FDAJAMA, 2005
- Imagining nanotechnology: cultural support for technological innovation in Europe and the United StatesPublic Understanding of Science, 2005
- PUBLIC DELIBERATION, DISCURSIVE PARTICIPATION, AND CITIZEN ENGAGEMENT: A Review of the Empirical LiteratureAnnual Review of Political Science, 2004
- Site-specific selfish genes as tools for the control and genetic engineering of natural populationsProceedings Of The Royal Society B-Biological Sciences, 2003